Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
Status:
RECRUITING
Trial end date:
2027-01-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program length of stay (LOS) and completion rate.
Phase:
PHASE2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston